0 items USD 0.00Search
Your search for "mrrpb5 global her2 negative breast cancer treatment market size status forecast 2019 2025" gave back 679711 results.
HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Market Analysis and Insights: Global HER-2 Negative Breast Cancer Market The global HER-2 Negative Breast Cancer market is projected to grow from US...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
Anti-HER2 Therapy is a class of medicines used to treat all stages of HER2-positive breast cancer and certain HER2-low breast cancers.In HER2-...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
HER2 Tumor Marker Testing is a diagnostic test used in oncology to assess the status of the HER2 gene and the presence of HER2 protein receptors in...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
These antibodies are used to treat metastatic (spread) breast cancer. It is effective against tumors that overexpress the HER2/neu protein. The...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
The global HER2 Tumor Marker Testing market size was valued at US$ million in 2022. With growing demand in downstream market, the HER2 Tumor Marker...
Catalog:
LPI
November 2023
Price: USD 3,660.00
The global HER2 Tumor Marker Testing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
November 2023
Price: USD 4,480.00
The global HER2 Antibody market size was valued at US$ 13680 million in 2023. With growing demand in downstream market, the HER2 Antibody is forecast...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global HER2 Tumor Marker Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a...
Catalog:
GIR
November 2023
Price: USD 3,480.00
A CDK (cyclin-dependent kinase) inhibitor is any chemical that inhibits the function of CDKs. They are used to treat cancers by preventing...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Chemotherapy is systemic drug treatment intended to stop cancer cells from dividing and growing. Many different types of chemotherapy drugs are used...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Anti-HER2 Therapy is a class of medicines used to treat all stages of HER2-positive breast cancer and certain HER2-low breast cancers.In HER2-...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
